Monoclonal Antibodies The approach (s), which is/are currently followed to produce human monoclonal antibodies, is/are known as transformation of antigen specific B lymphocytes (EBV) combination of EB Vand hybridoma techniques all of these hybridization of 6-thioguanine-resistant human plasmacytoma with immune human lymphocytes transformation of antigen specific B lymphocytes (EBV) combination of EB Vand hybridoma techniques all of these hybridization of 6-thioguanine-resistant human plasmacytoma with immune human lymphocytes ANSWER DOWNLOAD EXAMIANS APP
Monoclonal Antibodies Some cross reactions with monoclonal antibodies (MAbs) can occur. Unexpected cross reactions occur more frequently with IgA IgG IgE Ig MAbs IgA IgG IgE Ig MAbs ANSWER DOWNLOAD EXAMIANS APP
Monoclonal Antibodies Preliminary clinical results with a humanized antibody against the interleukin-2 receptor have suggested the absence of human immune response against murine proteins (HAMA) response poor recognition of immunoglobulin, Ig constant regions All of these presence of HAMA response absence of human immune response against murine proteins (HAMA) response poor recognition of immunoglobulin, Ig constant regions All of these presence of HAMA response ANSWER DOWNLOAD EXAMIANS APP
Monoclonal Antibodies The cross linkage of antigens by antibodies is known as agglutination complement fixation all of these a cross reaction agglutination complement fixation all of these a cross reaction ANSWER DOWNLOAD EXAMIANS APP
Monoclonal Antibodies In monoclonal antibody technology, tumor cells that can replicate endlessly are fused with mammalian cells that produce an antibody. The result of this cell fusion is a lymphoblast natural killer cell hybridoma myeloma lymphoblast natural killer cell hybridoma myeloma ANSWER DOWNLOAD EXAMIANS APP
EXAMIANS